About This eModule
The mission of the American Epilepsy Society (AES) is to
advance clinical, research, educational, and advocacy efforts on behalf of
persons with epilepsy. The cornerstone of these efforts is in high-quality
programming that has a global impact. To that end, fair and balanced content
without bias is essential. Additionally, presentation techniques and materials
need to be top-notch in order to maximize effective dissemination to a broad
audience.
The CME Primer is a set of guidelines for designing and
developing AES educational activities that will award continuing medical
education (CME) credit. This primer is organized into two sections: first, it
will describe the CME guidelines and review process, and second, it will
outline the best practices for creating an effective presentation.
Faculty
Derek Bauer, MD,
University of Virginia, Charlottesville, VA
Tyson Burghardt, MD,
Michigan State University, East Lansing, MI
Jay Salpekar, MD,
FANPA, Kennedy Krieger Institute, Baltimore, MD
Elaine Seto, MD, PhD, Texas
Children’s Hospital, Houston, TX
Courtney Wusthoff, MD,
Stanford Medicine, Palo Alto, CA
Learning Objectives
- Differentiate between relevant and irrelevant conflicts of interest as defined by the ACCME
- Develop actionable, measurable learning objectives for CME content
- Prepare CME eligible presentations that fair, balanced, and scientifically rigorous
It is the policy of the American Epilepsy Society (AES) to ensure balance, independence, objectivity and scientific rigor. All individuals involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. Conflicts of interest will be resolved by AES prior to an educational activity being delivered to learners.
Planning Committee, Faculty, Reviewers' Disclosures of Financial Relationships
In accordance with the ACCME Standards for Commercial Support, the AES requires that any person who is in a position to control content of a CME activity must disclose all relevant financial relationships that they have with a commercial interest. Unless otherwise indicated (*), none of the planners or faculty of this activity have any financial relationships to disclose. All relevant financial relationships with commercial interests have been mitigated. The following individuals contributed to this activity’s content.
Planning Committee and Faculty
Derek Bauer, MD
Tyson Burghardt, MD
Jay Salpekar, MD, FANPA
Elaine Seto, MD, PhD
Courtney Wusthoff, MD
CME Reviewer
Kelly Knupp, MD
American Epilepsy Society Staff Planners
Cristina Graham
Kandice Kidd, MA
Resolution of Conflicts of Interest
It is the policy of the American Epilepsy Society to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. In accordance with the ACCME Standards for Commercial Support of CME, the AES implemented the mechanisms of prospective peer review of this CME activity, to identify and resolve any conflicts. Additionally, the content of this activity is based on the best available evidence.
Accreditation
The American Epilepsy Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
For more information regarding contact hours, please call American Epilepsy Society 312.883.3800 or education@aesnet.org.
Credit Designation
The American Epilepsy Society designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME Certificate
To receive credit for your participation in this activity, please complete the evaluation survey provided at the conclusion of the activity.
Unapproved Use Disclosure
The American Epilepsy Society requires CME authors to disclose to learners when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information. Information about pharmaceutical agents/devices that is outside of U.S. Food and Drug Administration approved labeling may be contained in this activity.
Disclaimer
This CME activity is for educational purposes only and does not constitute the opinion or endorsement of, or promotion by, the American Epilepsy Society. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label, investigational and/or experimental uses.